Advertisement

Lung

, Volume 168, Supplement 1, pp 142–153 | Cite as

Long-term drug treatment of asthma in children

  • K. F. Kerrebijn
Asthma: Inflammatory Mechanisms And Clinical Management With β2-Adrenoceptor Agents

Abstract

In this short review the pharmacologic and clinical effect of antiasthma drugs in children that is,β 2-agonists, theophylline, anticholinergics, disodiumcromoglycate/nedocromil sodium, and inhaled corticosteroids are described. Furthermore, a medication plan for maintenance treatment is presented.

Key words

Childhood asthma Antiasthma drugs Pharmacology Treatment plan 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barnes P (1986) Neural control of human airways in health and disease. State of the art. Am Rev Respir Dis 134:1289–1314PubMedGoogle Scholar
  2. 2.
    Kay AB, Nadel JA, Henson PM, Irvin C, Hunninghake GW, Lichtenstein LM (1989) The role of inflammatory cells and their mediators in bronchial hyperresponsiveness. In: Holgate ST, Burney PJ, Drazen JM, Hargreave FE, Kay AB, Kerrebijn KF, Reid LM (eds) The role of inflammatory mediators in bronchial hyperresponsiveness. Blackwell Scientific Publications, Oxford (London, Edinburgh, Boston, Melbourne), pp 151–178Google Scholar
  3. 3.
    Drazen JM, Hirschman C, Macklem PT, Pauwels R, Permutt S, Persson C (1989) Physiology. In: Holgate ST, Burney PJ, Drazen JM, Hargreave FE, Kay AB, Kerrebijn KF, Reid LM (eds) The role of inflammatory mediators in bronchial hyperresponsiveness, Blackwell Scientific Publications, Oxford, pp. 108–150Google Scholar
  4. 4.
    Kerrebijn KF, Howell JBC, Jongejan RC, Postma DS, Sears MR, Woolcock AJ. Clinical presentation of airway hyperresponsiveness. In: Holgate ST, Burney PJ, Drazen JM, Hargreave FE, Kay AB, Kerrebijn KF, Reid LM (1989) (eds) The role of inflammatory mediators in bronchial hyperresponsiveness. Blackwell Scientific Publications, Oxford, pp. 1–35Google Scholar
  5. 5.
    Anderson SD (1985) Issues in exercise-induced asthma. J Allergy Clin Immunol 76:763–772PubMedCrossRefGoogle Scholar
  6. 6.
    Strope GL, Stempel DA (1984) Risk factors associated with the development of chronic lung disease in children. Pediatr Clin N Am 31:757–771Google Scholar
  7. 7.
    McFadden ER (1984) Pathogenesis of asthma. J Allergy Clin Immunol 73:413–424PubMedCrossRefGoogle Scholar
  8. 8.
    Siegel SC, Rachelefsky GS (1985) Asthma in infants and children I. J Allergy Clin Immunol 76:1–14PubMedCrossRefGoogle Scholar
  9. 9.
    Dolovich J, Hargreave F (1981) The asthma syndrome: inciters, inducers and host characteristics. Thorax 36:641–644CrossRefGoogle Scholar
  10. 10.
    Larsen GL (1985) Late-phase reactions: Observations on pathogenesis and prevention. J Allergy Clin Immunol 76:665–669PubMedCrossRefGoogle Scholar
  11. 11.
    Drug therapy for asthma. Jenne JW, Murphy S (1987) (eds). Lung biology in health and disease. Marcel Dekker, New York, Basel, Vol 31Google Scholar
  12. 12.
    Beasley R, Rocke WR, Roberts JA, Holgate ST (1989) Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 139:806–817PubMedGoogle Scholar
  13. 13.
    Hargreave FE, Dolovich J, Newhouse MT (1990) The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol (in press)Google Scholar
  14. 14.
    Newman SP (1984) Therapeutic aerosols. In: Aerosols and the lung in clinical and experimental aspects. Clarke SW, Pavia D (eds) Butterworths, London, pp 197–224Google Scholar
  15. 15.
    Sleigh MA, Blake JR, Liron N (1988) The propulsion of mucus by cilia. Am Rev Respir Dis 137:726–741PubMedGoogle Scholar
  16. 16.
    Kerrebijn KF Beta-agonists. In: Kaliner M, Barnes PJ, Persson CGA (eds) Asthma and airway hyperresponsiveness: pathophysiology and treatment. Lung biology in health and disease, Marcel Dekker, New York, Basel (in press)Google Scholar
  17. 17.
    Jenne JW, Ahrens RC (1988) Pharmacokinetics of beta-adrenergic compounds. In: Kaliner MA, Barnes P (eds) The airways neural control in health and disease. Lung biology in health and disease, Vol. 33. Marcel Dekker, New York, Basel, pp 213–258Google Scholar
  18. 18.
    Goldie RG, Spina D, Henry PJ, Lulich KM, Paterson JW (1986) In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline. Br J Pharmacol 22:669–676Google Scholar
  19. 19.
    Ullman A, Svedmyr N (1988) Salmeterol, a new long-acting inhaled beta-2-adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 43:674–678PubMedCrossRefGoogle Scholar
  20. 20.
    Prendiville A, Green S, Silverman M (1987) Paradoxical response to nebulised salbutamol in wheezy infants assessed by partial expiratory flow-volume curves. Thorax 42:86–91PubMedCrossRefGoogle Scholar
  21. 21.
    Van Essen-Zandvliet EEM, Kerrebijn KF. The effect of anti-asthma drugs on bronchial hyperresponsiveness. In: Allergic inflammatory mediators and bronchial hyperreactivity, Immunol Allergy Clin North Am (in press)Google Scholar
  22. 22.
    Conolly ME, Jenne JW, Hui KK, Borst SE (1988) Beta-adrenergic tachyphylaxis (desensitization) and functional antagonism. In: Kaliner MA, Barnes PJ (eds) Lung biology in health and disease, Vol. 33. Marcel Dekker, New York, Basel, pp 259–296Google Scholar
  23. 23.
    Lindgren SB, Larsson S (1982) Inhalation of terbutaline sulphate through a conventional actuator or a pear shaped tube: effect and side effect. Eur J Respir Dis 63:504–509PubMedGoogle Scholar
  24. 24.
    Lichtenstein LM, Margolis S (1968) Histamine release in vitro: inhibition by cathecholamines and methylxanthines. Science 161:902–903PubMedCrossRefGoogle Scholar
  25. 25.
    Guillot G, Fornaris M, Bedier M, Orehek J (1984) Spontaneous and provoked resistance in isolated human bronchi. J Allergy Clin Immunol 74:713–718PubMedCrossRefGoogle Scholar
  26. 26.
    Nielson CP, Crowley JJ, Morgan ME, Vestal RE (1988) Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3′,5′-adenosine monophosphate. Am Rev Respir Dis 137:25–30PubMedGoogle Scholar
  27. 27.
    Persson CGA (1988) Xanthines as antiinflammatory drugs. Letter. J Allergy Clin Immunol 81:615–616CrossRefGoogle Scholar
  28. 28.
    Martin GL, Atkins FC, Dunsky EH, Zweiman B (1980) Effects of theophylline, terbutaline and prednisone on antigen induced bronchospasm and mediator release. J Allergy Clin Immunol 66:204–212PubMedCrossRefGoogle Scholar
  29. 29.
    Nissim JE, Bleecker ER, Norman PS, Menkes H, Permutt S, Rosenthal RR (1980) Failure of aminophylline pretreatment to prevent antigen-induced bronchospasm. J Allergy Clin Immunol 65:180Google Scholar
  30. 30.
    Pauwels R, van Rentherghem D, van der Straeten M, Johanneson N, Persson CGA (1985) The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol 76:583–590PubMedCrossRefGoogle Scholar
  31. 31.
    Mapp C, Boschetto P, Dal Vecchio L, Crescioli S, de Marzo N, Paleari D, Fabbri LM (1987) Protective effect of antiasthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocyante in sensitized subjects. Am Rev Respir Dis 136:1403–1407PubMedGoogle Scholar
  32. 32.
    Ellis EF (1984) Inhibition of exercise-induced asthma by theophylline. J Allergy Clin Immunol 73:690–692PubMedCrossRefGoogle Scholar
  33. 33.
    Magnussen H, Reuss G, Jörris R (1988) Methylxanthines inhibit exercise-induced bronchoconstriction at low serum theophylline concentrations and in a dose-dependent fashion. J Allergy Clin Immunol 51:531–537CrossRefGoogle Scholar
  34. 34.
    Merland N, Cartier A, L’Archevèque J, Ghezzo H, Malo JL (1988) Theophylline minimally inhibits bronchoconstriction induced by dry cold air inhalation in asthmatic subjects. Am Rev Respir Dis 137:1304–1308PubMedGoogle Scholar
  35. 35.
    Jenne JW (1987) Physiology and pharmacodynamics of the xanthines. In: Jenne JW, Murphy S (eds) Drug therapy for asthma. Lung biology in health and disease, Vol. 31. Marcel Dekker, New York, Basel, pp 297–334Google Scholar
  36. 36.
    Hendeles L, Messanari M, Weinberger M (1985) Update on the pharmacokinetics of theophylline. Chest 88 (Suppl.):103S-111SPubMedGoogle Scholar
  37. 37.
    Kelly HW (1987) Theophylline toxicity. In: Jenne JW, Murphy S (eds) Drug therapy for asthma. Lung biology in health and disease, Vol. 31. Marcel Dekker, New York, Basel, pp 925–951Google Scholar
  38. 38.
    O’Driscoll BR, Taylor RJ, Horsley MG, Chambers DK, Bernstein A (1989) Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1:1418–1420PubMedCrossRefGoogle Scholar
  39. 39.
    Rebuck AS, Chapman KR, Abbound R (1987) Nebulised anticholinergic and sympathomimetic treatment of obstructive airways disease in the emergency room. Am J Med 82:59–64PubMedCrossRefGoogle Scholar
  40. 40.
    Leung KBP, Flint KC, Brostoff J, Hudspith BN, Mc I Johnson N, Lan HYA, Liu WL, Pearce FL (1988) Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. Thorax 43:756–761PubMedCrossRefGoogle Scholar
  41. 41.
    Kay AB, Walsh GM, Moqbel R, MacDonald AJ, Nagakura T, Carroll MP, Richerson HB (1987) Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol 80:1–8PubMedCrossRefGoogle Scholar
  42. 42.
    Murphy S (1987) Cromolyn sodium. In: Jenne JW, Murphy S (eds) Drug therapy for asthma. Lung biology in health and disease, Vol. 31. Marcel Dekker, New York, Basel, pp 677–678Google Scholar
  43. 43.
    Moqbel R, Cromwell D, Walsh GM, Wardlaw AJ, Kurlak L, Kay AB (1988) Effects of nedocromil sodium (TiladeR) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells. Allergy 43:268–276PubMedCrossRefGoogle Scholar
  44. 44.
    Dannon M, Chavis C, Crastes de Paulet A, Michel FB, Godard P (1986) Effect of nedocromil sodium on TxB21, LTB4 and LTD4 synthesis by alveolar macrophages from asthmatic patients. Eur J Respir Dis 69(Suppl 147):206–209Google Scholar
  45. 45.
    Spry CFJ, Kumaraswani V, Tai PC (1986) The effect of nedocromil sodium on secretion from human eosinophils. Eur J Respir Dis 69 (Suppl 147):241–243Google Scholar
  46. 46.
    Horn CR, Jones RM, Lee D, Brennan SR (1984) Bronchodilator effect of disodium cromoglycate administered as a dry powder in exercise-induced asthma. Br J Pharmacol 18:798–801Google Scholar
  47. 47.
    Hasham F, Kennedy JD, Jones RS (1981) Actions of salbutamol, disodium cromoglycate and placebo administered as aerosols in acute asthma. Arch Dis Child 56:722–725PubMedCrossRefGoogle Scholar
  48. 48.
    Dixon M, Jackson DM, Richards IM (1980) The action of sodium cromoglycate on “C” fibre endings in the dog lungs. Br J Pharmacol 70:11–13PubMedGoogle Scholar
  49. 49.
    Joos GS, Pauwels RA, van der Straeten ME (1988) The mechanism of tachykinin induced bronchoconstriction in the rat. Am Rev Respir Dis 137:1038–1044PubMedGoogle Scholar
  50. 50.
    Erjefält I, Persson CGA (1986) Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumen. Acta Physiol Scand 128:653–654PubMedCrossRefGoogle Scholar
  51. 51.
    Church MK, Warner JO (1985) Sodium cromoglycate and related drugs. Clin Allergy 15:311–320PubMedCrossRefGoogle Scholar
  52. 52.
    Mattoli S, Foresi A, Corbo GM, Valente S, Ciappi G (1987) Effects of two doses of cromolyn on allergen-induced late asthmatic response and increased responsiveness. J Allergy Clin Immunol 97:747–754CrossRefGoogle Scholar
  53. 53.
    Holgate ST (1986) Clinical evaluation of nedocromil sodium in the treatment of asthma. Eur J Respir Dis 69(Suppl 147):149–159Google Scholar
  54. 54.
    Murphy S (1987) Cromolyn sodium. In: Jenne JW, Murphy S (eds) Drug therapy for asthma. Lung biology in health and disease, Vol. 31. Marcel Dekker, New York, Basel, pp 688–690Google Scholar
  55. 55.
    Fuller RW, Collier JG (1984) Sodium cromoglycate and atropine block the fall in FEV1 but not the cough induced by hypotonic mist. Thorax 39:766–770PubMedCrossRefGoogle Scholar
  56. 56.
    Sheppard D, Nadel JA, Boushey HA (1981) Inhibition of sulfur dioxide-induced bronchoconstriction by disodium cromoglycate in asthmatic subjects. Am Rev Respir Dis 124:257–259PubMedGoogle Scholar
  57. 57.
    Chapter on preclinical safety and clinical pharmacology studies (1986). In: Inflammation: Its clinical relevance in airway diseases. Eur J Respir Dis 69(Suppl 147):246–304Google Scholar
  58. 58.
    Bel E, Timmers MC, Hermans J, Dijkman JH, Sterk PJ (1990) The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacoline in non-atopic asthmatics. Am Rev Respir Dis 141:21–28PubMedGoogle Scholar
  59. 59.
    Schleimer RP (1990) Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. In: Kaliner M, Clark T (eds) Corticosteroids, their biologic mechanisms and application to the treatment of asthma. Am Rev Respir Dis (Suppl) (in press)Google Scholar
  60. 60.
    Shenfield GM, Hodson ME, Clark SW, Paterson JW (1975) Interaction of corticosteroids and cathecholamines in the treatment of asthma. Thorax 30:430–435PubMedCrossRefGoogle Scholar
  61. 61.
    Kerrebijn KF (1990) Use of topical corticosteroids in the treatment of childhood asthma. In: Kaliner M, Clark T (eds) Corticosteroids, their biologic mechanisms and application to the treatment of asthma. Am Rev Respir Dis (Suppl) (See ref 60)Google Scholar
  62. 62.
    De Baets FM, Goeteyn M, Kerrebijn KF (1990) The effect of two months treatment with inhaled budesonide on the bronchial responsiveness to histamine and house-dust mite antigen in asthmatic children. Am Rev Respir Dis (in press)Google Scholar
  63. 63.
    Dahl R, Johansson SA (1982) Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis 63 (Suppl 122):167–175Google Scholar
  64. 64.
    Henriksen JM (1985) Effect of glucocorticosteroid inhalation therapy on exercise-induced asthma. Br Med J 291:248–249CrossRefGoogle Scholar
  65. 65.
    Lundgren R, Söderberg M, Hörstedt P, Stenling R (1988) Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1:883–889PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1990

Authors and Affiliations

  • K. F. Kerrebijn
    • 1
  1. 1.Division of Paediatric Pulmonary MedicineErasmus UniversityRotterdamThe Netherlands

Personalised recommendations